WHO statement on AstraZeneca COVID-19 vaccine safety signals

Schools weigh whether to seat students closer together BOSTON (AP) — New evidence that it may be safe for schools to seat students 3 feet apart — half of the previous recommended distance — could offer a way to return more of the nation's children to... AP NEWS

BOSTON (AP) — New evidence that it may be safe for schools to seat students 3 feet apart — half of the previous recommended distance — could offer a way to return more of the nation’s children to classrooms with limited space.

https://www.nytimes.com/live/2021/03/16/world/covid-19-coronavirus#halting-a-key-vaccine-across-europe-weakens-an-already-faltering-rollout

The suspension of the use of the AstraZeneca Covid-19 vaccine by most governments across Europe has further set back an already fraught inoculation campaign on the continent even as the bloc’s main drug regulator said there was no indication that vaccination has caused side effects such as blood clots.

No country in the European Union is on pace to reach its goal of vaccinating 70 percent of its population by September. Hundreds of millions of people across the continent are still constrained by some of the most severe coronavirus restrictions in the world, and millions more are facing the prospect of rules being tightened further to tackle a third wave of the coronavirus.

Death in the prime of life: Covid-19 proves especially lethal to younger Latinos The coronavirus has disproportionately carved a path through the nation’s Latino neighborhoods, as it has in African American, Native American and Pacific Islander communities. Even more stunning: the deadly efficiency with which the virus has targeted Latinos in their 30s and 40s. Akilah Johnson Washington Post

...

Millions of people in dozens of countries have received the AstraZeneca Covid vaccine with few reports of ill effects, and its prior testing in tens of thousands of people found it to be safe.

But recently, blood clots and abnormal bleeding in a small number of vaccine recipients in European countries have cast doubt on its safety, although no causative link has been found between the patients’ conditions and the vaccine. The reports have prompted more than a dozen countries to either partly or fully suspend the vaccine’s use while the cases are investigated. Most of the nations said they were doing so as a precaution until leading health agencies could review the cases.